Floatz logo

Arsenic Trioxide

Acute Promyelocytic Leukemia

Quetzal TherapeuticsSmall moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Acute Promyelocytic Leukemia cohort.

Asset / SponsorPhaseRating
Vesanoid
The Affiliated People's Hospital of Ningbo University
Phase 4A
Cytosin-Arabinosid
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 4A
Idarubicine
Technische Universität Dresden
Phase 4A
Mitoxantrone
Technische Universität Dresden
Phase 4BBB
METHOTREXATE
Technische Universität Dresden
Phase 3BBB

View all 50 →

Same molecule, other indications

Arsenic Trioxide is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
71 / 100
View asset →
central nervous system neoplasmDormant
BB
Indicative ·
65 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →